Morgan Stanley
TLSI icon

Morgan Stanley’s TriSalus Life Sciences TLSI Stock Holding History

Morgan Stanley’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
401,814
+7,905
+2% +$31.4K ﹤0.01% 4900
2026
Q1 		$1.58M Buy
393,909
+28,654
+8% +$140K ﹤0.01% 4904
2025
Q4 		$2.55M Buy
365,255
+347,278
+1,932% +$1.94M ﹤0.01% 4641
2025
Q3 		$83.6K Sell
17,977
-38,351
-68% -$180K ﹤0.01% 6232
2025
Q2 		$307K Buy
56,328
+53,967
+2,286% +$290K ﹤0.01% 5679
2025
Q1 		$13K Buy
+2,361
New +$12.6K ﹤0.01% 6724
2024
Q4 		– Sell
-1,135
Closed -$5.23K – 8087
2024
Q3 		$5.23K Sell
1,135
-837
-42% -$4.43K ﹤0.01% 6908
2024
Q2 		$10.9K Sell
1,972
-11,337
-85% -$96.1K ﹤0.01% 6652
2024
Q1 		$130K Buy
13,309
+820
+7% +$7.57K ﹤0.01% 5889
2023
Q4 		$106K Buy
12,489
+11,352
+998% +$58.4K ﹤0.01% 5926
2023
Q3 		$5.82K Buy
+1,137
New +$9.31K ﹤0.01% 6877
2023
Q1 		– Sell
-4,050
Closed -$40.6K – 7824
2022
Q4 		$40.6K Hold
4,050
– – ﹤0.01% 6380
2022
Q3 		$40K Hold
4,050
– – ﹤0.01% 6504
2022
Q2 		$40K Hold
4,050
– – ﹤0.01% 6708
2022
Q1 		$40K Hold
4,050
– – ﹤0.01% 6808
2021
Q4 		$40K Sell
4,050
-154
-4% -$1.53K ﹤0.01% 6915
2021
Q3 		$42K Buy
4,204
+4,104
+4,104% +$40.2K ﹤0.01% 6795
2021
Q2 		$1K Sell
100
-125
-56% -$1.23K ﹤0.01% 7632
2021
Q1 		$2K Buy
+225
New +$2.28K ﹤0.01% 7284

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Morgan Stanley's TLSI Position: Q2 2026 in Review

Morgan Stanley increased its TriSalus Life Sciences (TLSI) stake by 2% in Q2 2026, buying an estimated $31.4K and bringing the position to 401,814 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4900.

Morgan Stanley first reported a position in TLSI in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.55M in Q4 2025. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Morgan Stanley held 401,814 shares of TriSalus Life Sciences worth $1.83M as of Q2 2026.
  • Morgan Stanley bought 7,905 TriSalus Life Sciences shares in Q2 2026, an estimated $31.4K.
  • TriSalus Life Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4900 holding.
  • Morgan Stanley first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 19 quarters since.
  • Morgan Stanley's TriSalus Life Sciences position peaked at $2.55M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.